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Quantitation of  type I  SGN 
peripheral axons after KA treatment 
when Ca2+ influx is blocked.  
IEM 1460 (IEM) selectively blocks 
GluR2 subunit-lacking (Ca2+-permeable) 
AMPA receptors.  Isradipine  and 
verapamil are both potent and selective 
L-type voltage-gated Ca2+ channel 
blocker.  Mannitol is used to correct 
osmolarity. Type I SGN peripheral axons 
contacting IHCs and those not contacting 
but remaining within 50 µm below the 
base of the IHCs were quantified. 8-20 
confocal series (n) analyzed for each 
condition.  Error bar  is SEM. Note that 
blockade of  Ca2+  entry  by AMPA 
receptor is synergistic  with balanced 
osmolarity. 
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      We previously showed that brief exposure to high levels of  glutamate receptor agonists cause 
degeneration of  99% of type I SGN(spiral ganglion neuron) peripheral axons (“dendrites”, “peripheral 
processes”)  and inner hair cell (IHC) -SGN synapses. Reinnervation of IHCs occurs and new IHC-SGN 
synapses form. However, not all axons regenerate and the number of postsynaptic densities (PSDs) does 
not recover to the pre-trauma level. This is an in vitro model of noise-induced damage to the cochlea. 
     With the in vitro model of denervation and reinnervation of IHCs following excitotoxic trauma , we 
ask:  
1. Is excitotoxic trauma to type I SGN peripheral axons in cochlea caused by excessive calcium entry 
into the SGNs solely?  
       Excitotoxicity is typically due to Ca2+ entry and activation of Ca2+-dependent proteases and other 
enzymes. We show that excitotoxic trauma to type I SGN peripheral axons in cochlea is caused by Ca2+  
influx, but not entirely. We also show evidence of  contribution by osmotic damage.  
2. What is the  route of calcium entry to SGNs?   
      Here we  show that blocked Ca2+ influx via Ca2+ permeable AMPA receptors but not via  L-type 
voltage gated calcium channels (L-VGCCs) protects type I SGN peripheral axons from degeneration after 
kainic acid (KA) treatment. 
3.What is the role of postsynaptic modulation of IHC-SGN synapses by second messenger systems?  
       cAMP signaling  via PKA upregulates AMPA receptors.  Our result show inhibition of cAMP-PKA 
signaling partially protects type I SGN peripheral processes from the initial degeneration due to 
excitotoxicity; in contrast, a cell membrane permeant cAMP analog cpt-cAMP exacerbated the initial 
degeneration . Because PKA is a downstream target of the D1 dopamine receptor, this result may help 
determine the role of dopaminegic  efferent systems in noise-induced trauma  in  cochlea in vivo.  
       Blockade of  Ca2+  entry  by AMPA receptor is synergistic or additive with  inhibition of  cAMP 
signaling or  balanced osmolarity. 
       We also show complex actions of cAMP signaling in the regeneration of IHC-SGN synapses.       
1.   Excessive calcium influx contributes to the degeneration of  type I SGN peripheral axons following excitotoxic trauma. We also  show 
evidence of  contribution by osmotic damage. 
2.   Blockade of  calcium entry   via  Ca2+  permeable AMPA receptors,  but not via L-VGCCs  partially protects type I SGN peripheral axons 
from degeneration following excitotoxic trauma. However,  blockade of L-VGCC potentiates protection when Ca2+ permeable AMPA 
receptors  blocked.   
3.   cAMP signaling, via PKA, upregulates AMPA receptors. We show that cAMP  signaling inhibition  is protective against glutamate 
excitotoxicity. Separately, we show that complex actions of cAMP signaling are involved in the regeneration of IHC-SGN synapses.  
4.   This in vitro system mimics critical aspects of in vivo excitotoxic damage to  IHC-SGN synapses,  such as that occurring as a 
consequence of noise damage. This provides a model system to study protection and recovery from noise.  
Introduction  
Methods 
1.  Organotypic cochlear explants, composed of organs of Corti and associated 
spiral ganglia, prepared from the middle turn of P4-6 rat pups and cultured for 
up to 4 days in DMEM/N2 with 10% fetal bovine serum. 
2.  Excitotoxic trauma was caused by exposing the explants, after 24 h in culture, 
to the glutamate receptor agonist  NMDA and kainic acid (0.5 mM) for 2h 
(“NK” treatment), or only kainic acid (“KA “ treatment ).  
3.  For degeneration experiments: before the KA treatment ,  explants were 
preconditioned with different compounds such as  cpt-CAMP, H89  or calcium 
channel inhibitors  for 40min. Compounds were also included in the following 
KA  treatment. The cultures were then fixed and prepared for 
immunofluorescence  (IF). For regeneration experiments:  explants were 
maintained for up to 72h post NK treatment.  
4.  Antibodies used for IF: anti-NF200 to label the SGNs and their  peripheral axons; anti-peripherin to lable type II SGN 
peripheral  axons; anti-myosin VI to label hair cells; anti-PSD-95 to label the postsynaptic density.    
5.    Western blotting analysis of rat cochlear and adult rat brain homogenates was performed using  standard protocol. Spiral 
ganglion and organs of Corti from rat cochleae were separated by dissection before homogenization .  Primary antibodies 
used for western blotting  includes: Rb GluR1 anti-serum 1:500 (from Dr. Johannes Hell), ms GluR2 1:250 (Chemicon) , ms 
GluR3 1:250 (Chemicon).  
6.   Imaging and analysis : A Leica TCS P2  Spectra confocal system on a Leica DMIRE2 microscope was used to capture series 
of images along the z-axis (“z-sections”) at a step of 0.6µM. Leica software was used for 3D analyses and quantification of 
PSD95 puncta and SGN peripheral processes (“peripheral axons”). We quantify the extent of  the denervation by counting 
the remaining type I axon-IHC contacts as well as type I SGN afferent terminals within 50 µm below the base of the IHCs; 
we quantify the  reinnervation  by counting type I axon-IHC contacts and the number of PSDs on each IHC.  
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Characteristic innervation pattern of 
SGNs .Type 1 SGN peripheral axons are 
the radial fibers  that innervate the IHC 
row.  
Control 
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Type 1, but not type 2, SGN peripheral axons 
degenerate following excitotoxic trauma.  A-D: 
Explants shown were fixed at 1 DIV, immediately after 
NK treatment. As in Figure 2B-D, hair cells are labeled 
with anti-myosin 6 (blue), type 1 and type 2 SGN 
peripheral processes with anti-NF200 (A,B,D, red), and 
type 2 SGN peripheral axons with anti-peripherin (C,D, 
green). Merged NF200 and peripherin images are 
shown in D (yellow). scale bar :A:,20 µm; B-D: 10 
µm .)  E: Counts of contacts between SGN axons and 
IHCs in 1 DIV cultures immediately after 2 h NMDA/
kainate (NK) or kainate (KA) treatment, or no NK 
controls. Shown are means ± SEM.  
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Representative images of SGN-IHC 
contacts after KA when different  
compounds were included. HCs (red) 
and peripheral processes of SGNs (green) 
are visualized by IF.  
Final concentrations for compounds are: 
IEM 50µM, Isradipine 10µM,verapamil 
10µM, Mannitol 1mM.. All images have 
the same scale bar as KA/ Control except 
the  lower  power KA/IEM image, in 
which scale bar is adjusted accordingly.  
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Quantitation of  type I  SGN-IHC afferent terminals after KA 
treatment when cAMP signaling is enhanced and inhibited. 
 Cyclic AMP (cAMP) is an activity-dependent intracellular signal.              
Cpt-cAMP is a cAMP agonist;H89 is a selective inhibitor of PKA. Type I 
SGN afferent terminals per IHC is plotted as histogram  shown above. 
14-24 confocal series (n) analyzed for each condition.  Final concentration 
for compounds: Cpt-CAMP  10 µM, H89 10 µM, IEM 50 µM, Mannitol 1 
mM. Error bar is SEM. Note that blockade of  Ca2+  entry  by AMPA 
receptor is synergistic with  inhibition of  cAMP signaling  
Ty
pe
 I 
SG
N
 p
er
ip
he
ra
l a
xo
ns
  p
er
 IH
C
  
Representative images of afferent terminals immediately post-KA.  
Quantitation of  synaptogenesis on IHCs by type I  SGN after excitotoxic trauma. cpt-cAMP (1mM)  inhibits and H89 enhances 
IHC-SGN afferent  synaptogenesis. 
Quantitation of  reinnervation IHCs by type I  SGN after excitotoxic trauma.  cpt-cAMP (1mM)  enhance multiple IHCs 
innervation and H89 inhibits multiple-IHC innervation. Quantitation of axons per IHC in cpt-cAMP and H89 looks similar may be 
due to multiple-IHC innervation pattern by  single peripheral axon in cpt-cAMP group. 
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Representative images  of IHC-
SGN synapses 72h post trauma.   
Explants were maintained 72h post 
excitotoxic trauma.  PSD95 (green), 
HCs (blue), peripheral axons of 
SGNs(red) are visualized by IF.  
Scale bar= 10 µm. 
Immunoblot  analysis  of glutamate subunits in rat cochlea and brain.  In 
postnatal cochleae,  all the glutamate subunits  proteins have a molecular 
weights of  110kDa. GluR2   expression  was not detected in  postnatal day 5 
spiral ganglion (SG) or  organs of Corti (OC, terminals of SGNs are also 
included), which is consistent with the observation that calcium permeable 
AMPA receptor is important in  excitotoxic trauma; GluR3 was detected in 
both SGNs and OCs.  Note that exposure time for  GluR1, 2 are  32 times 
longer than for GluR3.  GluR1 subunit  is a possible downstream target of 
PKA signaling. Here we show that GluR1 could be detected in SGN-HC 
terminals  in OC, albeit at low levels. 
